Alport syndrome is a dubious disease in the area of infectious respiratory digestive and endocrine disorders, clinical manifestations are complex and often involve multi-systematic strain. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory and precision medicine, many previously difficult-to-treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Alport syndrome. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1. Remote pre-diagnosis: pre-examination of medical records, precise diagnostic directions and medical advice by the team of experts; 2.
Interviews in China: arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: one-stop services: providing medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: Establishment of a chronic disease management file, continuous monitoring of disease changes and treatment effects.
Support for remote pre-diagnosis, visiting interviews, full translation and escort.